RxDoctor Payments Data
★ My doctorsLook up a doctor →

Shawna Deeves

Psychiatry · San Antonio, TXNPI 1891721973

Payments from drug & device makers

$3,650in general payments, 2019–2025

Across 195 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$684
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$540
  • Otsuka America Pharmaceutical, Inc.$356
  • Johnson & Johnson$353
  • Lundbeck LLC$253
  • Vanda Pharmaceuticals Inc.$214
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,59198%
  • Education$592%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie39$684
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)35$540
Otsuka America Pharmaceutical, Inc.14$356
Johnson & Johnson15$353
Lundbeck LLC14$253
Vanda Pharmaceuticals Inc.10$214
Corium, LLC17$210
Takeda Pharmaceuticals U.S.A., Inc.9$193
Teva Pharmaceuticals USA, Inc.10$183
Axsome Therapeutics, Inc.6$112
Alkermes, Inc.4$110
Ironshore Pharmaceuticals Inc.5$79
E.r. Squibb & Sons, L.L.C.3$70
Supernus Pharmaceuticals, Inc.3$63
Almatica Pharma LLC2$52
Biogen2$48
Avanir Pharmaceuticals, Inc.2$34
Idorsia Pharmaceuticals US Inc2$32
Neurocrine Biosciences, Inc.1$29
Eisai Inc.1$19
Tris Pharma Inc1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,650 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$1,769
Divalproex Sodium ErDivalproex Sodium25$1,054
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$910
Aripiprazole35$833
Gabapentin37$728
Lamotrigine42$724
Duloxetine Hcl39$694
Trazodone Hcl63$567
Clonazepam36$345
Venlafaxine Hcl ErVenlafaxine Hcl28$334
Fluoxetine Hcl17$323
Quetiapine Fumarate26$321
Olanzapine12$287
Sertraline Hcl29$267
Bupropion XlBupropion Hcl11$255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$52$26729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →